Treatment tinea cruris topical terbinafine Twenty-three patients randomized double-blind trial terbinafine cream versus vehicle placebo treatment tinea cruris patient negative initial culture patients dropouts poor study compliance terbinafine adverse event placebo patients efficacy treatment terbinafine-treated placebo-treated groups similar age sex duration disease prior therapy size location lesion organism factors cream effective vehicle cream reduction signs symptoms tinea cruris addition conversion rate negative culture normal microscopy findings terbinafine-treated group Clinical results evaluation mycologic tests end therapy terbinafine rapid effective treatment tinea cruris placebo vs cure rate Follow-up cure rates findings significant adverse events terbinafine treatment 